This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dr Reddy Laboratories Ltd (RDY)

NYSE: Health Care

Company Balance Sheet
Mar 2015 Mar 2014 Mar 2013 Mar 2012
Assets
Cash and Equivalents 86.25M 141.22M 94.42M 145.06M
Receivables 806.12M 573.74M 597.07M 509.61M
Inventories 408.21M 400.91M 397.01M 380.44M
Other Current Assets 56.72M 198.62M 144.41M 128.27M
Total Current Assets 1.92B 1.73B 1.58B 1.38B
Property, Plant & Equipment, Gross 1.25B 1.17B 1.08B 1.01B
Accumulated Depreciation & Depletion 480.34M 429.36M 389.89M 355.55M
Property, Plant & Equipment, Net 768.96M 742.32M 695.02M 653.57M
Intangibles 208.67M 188.30M 199.02M 222.56M
Other Non-Current Assets 73.75M 21.74M 21.47M 15.43M
Total Non-Current Assets 1.20B 1.11B 1.04B 973.60M
Liabilities & Shareholder Equity
Total Assets 3.11B 2.84B 2.62B 2.35B
Accounts Payable 179.98M 175.51M 218.02M 186.80M
Short Term Debt 460.82M 401.07M 443.60M 312.08M
Other Current Liabilities 165.26M 326.81M 324.39M 355.49M
Total Current Liabilities 1.02B 903.39M 986.01M 854.37M
Long Term Debt 228.77M 346.57M 232.05M 321.12M
Deferred Income Taxes 28.45M 45.85M 36.45M 22.25M
Other Non-Current Liabilities 54.03M 31.33M 18.56M 21.74M
Minority Interest 0.00 0.00 -18.38K 0.00
Total Non-Current Liabilities 311.25M 423.75M 287.43M 365.12M
Total Liabilities 1.33B 1.33B 1.27B 1.22B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.78B 1.52B 1.34B 1.13B
Common Par 13.62M 14.22M 15.60M 16.67M
Additional Paid In Capital 354.63M 360.15M 389.91M 411.54M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 1.34B 1.09B 823.70M 621.20M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 74.02M 55.91M 114.08M 79.87M
Total Capitalization 2.01B 1.86B 1.58B 1.45B
Total Equity 1.78B 1.52B 1.34B 1.13B
Total Liabilities & Stock Equity 3.11B 2.84B 2.62B 2.35B
Total Common Shares Outstanding 170.38M 170.11M 169.84M 169.56M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 170.31M 170.04M 169.78M 169.47M
Diluted Weighted Shares Outstanding 170.93M 170.70M 170.43M 170.18M
Number of Employees 20373 18421 16617 15200
Number of Part-Time Employees 0 0 0 0
RDY News

RDY Dr Reddy Laboratories Ltd

Chart of RDY

Analysts Ratings for RDY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET RDY ANALYST REPORT

Brokerage Partners

RDY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs